FDA approves SEPR's Clarinex

Sepracor (SEPR) partner Schering-Plough (SGP) received marketing approval from the FDA for their Clarinex desloratidine 5 mg tablets to treat seasonal allergic rhinitis (SAR) in adults and children 12...